CV CapsoVision, Inc.

NASDAQ
$5.99

CapsoVision, Inc. (CV) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $0.15 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.9% since its last earnings release on August 13, 2026.

CapsoVision Reported Earnings
Thursday, August 13, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.15)
Rev est $3.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.05

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CapsoVision, Inc.

CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and screening of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval.

Sector

Healthcare

Industry

Healthcare Info Services

Held By 1 ETFs, by dollar flow